Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validive for prevention of severe oral mucositis during chemoradiotherapy in oropharyngeal cancer
2021-000999-11Phase 2Terminated
- Sponsor
- Monopar Therapeutics Inc.
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in stomatitis comparing Validive with Placebo (2 arms). Primary endpoint: Occurrence of severe oral mucositis. Started Jun 2021; status: terminated.
02
Drugs
Clonidine Lauriad
03
Conditions
stomatitis
Beyond the preview
Go deeper on 2021-000999-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000999-11.